Aarau, Switzerland

Juerg Lareida

This inventor holds 1 USPTO granted patent. Top assignee: Lilly Icos LLC. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juerg Lareida. Retrieved from https://idiyas.com/inventor/juerg-lareida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juerg Lareida: Innovator in Neuropathic Treatment

Introduction

Juerg Lareida is a notable inventor based in Aarau, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of neuropathies. His innovative approach has led to the development of a unique medicament that addresses this challenging condition.

Latest Patents

Juerg Lareida holds a patent for a medicament designed for the treatment of neuropathies. The patent details compounds of formula (I) that include various alkyl and halogen substitutions. These compounds are formulated to provide effective chemotherapeutic treatment for neuropathies, showcasing Lareida's commitment to advancing medical science.

Career Highlights

Lareida is currently associated with Lilly Icos LLC, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication have positioned him as a valuable asset in the development of new treatments.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Juerg Lareida's work in developing a medicament for neuropathies exemplifies his innovative spirit and dedication to improving patient care. His contributions to the field are noteworthy and reflect the importance of continued research and development in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…